GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 26 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 6.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1 | -50.0% | 3,000 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $2 | -99.8% | 3,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 3,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $2,000 | -60.0% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $5,000 | 0.0% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $5,000 | -37.5% | 3,000 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $8,000 | -11.1% | 3,000 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $9,000 | -10.0% | 3,000 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $10,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|